Table 8 ANOVAs of neurite morphological outcomes.

From: Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers

Outcomea

Effect

χ2 (df)

p

ω2

Branchpoints per Cluster

Treatment

29.59 (1)

<0.001

0.603

Day

10.34 (1)

0.001

0.027

Treatment × Day

25.07 (1)

<0.001

0.166

Branchpoints per Cluster Area

Treatment

2.93 (1)

0.087

0.043

Day

41.08 (1)

<0.001

0.388

Treatment × Day

34.22 (1)

<0.001

0.282

Neurite Lengths per Cluster

Treatment

5.87 (1)

0.015

0.111

Day

16.24 (1)

<0.001

0.053

Treatment × Day

33.12 (1)

<0.001

0.427

Neurite Lengths per Cluster Area

Treatment

17.29 (1)

<0.001

0.158

Day

22.33 (1)

<0.001

0.533

Treatment × Day

31.77 (1)

<0.001

0.145

  1. aOutcomes are measured and analyzed separately.
Back to article page